Eris Lifesciences Ltd. - Research Center
540596 ERIS Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
821.00 |
684.13 |
586.77 |
628.96 |
564.85 |
Operating profit |
299.99 |
267.24 |
224.41 |
259.59 |
219.95 |
Interest |
13.39 |
14.71 |
1.74 |
1.25 |
0.41 |
Gross profit |
297.61 |
262.05 |
237.55 |
272.44 |
223.36 |
EPS (Rs) |
16.80 |
15.50 |
14.03 |
16.66 |
14.19 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
11.00 |
9.53 |
14.89 |
14.10 |
3.82 |
Stock adjustment |
-28.20 |
2.63 |
-5.23 |
7.72 |
-11.74 |
Raw material |
54.81 |
63.51 |
63.22 |
54.35 |
55.19 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
171.46 |
130.14 |
107.87 |
114.31 |
106.73 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
322.94 |
220.62 |
196.51 |
192.99 |
194.72 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
45.16 |
30.88 |
28.61 |
22.85 |
18.27 |
Taxation |
23.89 |
20.38 |
18.18 |
23.16 |
12.47 |
Net profit / loss |
228.55 |
210.79 |
190.76 |
226.43 |
192.62 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
13.60 |
13.60 |
13.59 |
13.59 |
13.58 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
36.54 |
39.06 |
38.24 |
41.27 |
38.94 |
GPM (%) |
35.77 |
37.78 |
39.48 |
42.37 |
39.28 |
NPM (%) |
27.47 |
30.39 |
31.71 |
35.21 |
33.87 |